NTI 1.28% 7.7¢ neurotech international limited

Ann: Further clinical benefit at 52 weeks in PANDAS/PANS patients, page-3

  1. 2,307 Posts.
    lightbulb Created with Sketch. 331
    This is very positive.

    If it doesn't pop the share price it doesn't matter because this is a strong orphan drug contender (H2 2024) with a good likelihood, in my opinion, of being out-licensed in the US.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.7¢
Change
-0.001(1.28%)
Mkt cap ! $78.33M
Open High Low Value Volume
7.9¢ 8.1¢ 7.7¢ $54.26K 684.2K

Buyers (Bids)

No. Vol. Price($)
3 98220 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 21369 1
View Market Depth
Last trade - 15.59pm 22/07/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.